Cipla has launched an innovative combination of 3 HIV/AIDS drugs, Viraday that needs to be taken just once a day for effective treatment. Cipla has launched an innovative combination of 3 HIV/AIDS ...

The drug is the first injectable therapy for HIV PrEP, protecting against infection with just six doses a year. GSK also said the new agreements with Aurobindo, Cipla, and Viatris could lead to ...

Truvada was also the overall highest-selling drug on the market for the treatment of HIV in 2006 ... such as Aurobindo and Cipla, have developed and received FDA approval for several other ...

In the following year, Cipla received approval from United States Food and Drug Administration (USFDA) to manufacture medicines in bulk for HIV. In 1994, Cipla introduced Deferiprone which was sta ...

“This includes HIV drugs - a large part of spending for treatment ... Aurobindo Pharma Ltd and Cipla Ltd, also tumbled on Monday. The Nifty Pharma index closed 2.65% lower.

Efforts to get Gilead’s experimental COVID-19 drug remdesivir to patients in badly-hit India are building after drug maker Cipla announced it had launched the drug in the country. The ...

New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have ...

MUMBAI/BENGALURU, Feb 28 (Reuters) - Tariffs should not influence decisions at Indian drug companies, Cipla's (CIPL.NS), opens new tab top executive said on Friday, as the industry braces for U.S ...

Cipla Ltd. has expressed optimism about exceeding ... has instructed organizations in other countries to stop disbursing HIV medications purchased with US aid, even if the drugs have already ...